Trials / Terminated
TerminatedNCT00758667
Chemically Assisted Capsulectomy-A New Clinical Approach
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Vanderbilt University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to make available an agent,Mesna, which can assist the surgeon during the procedure of capsulectomy.
Detailed description
Mesna is a FDA approved drug for the treatment of respiratory diseases and is used a protective agent against drugs in oncology patients. It has also been used in Gynecologic surgery and ENT. Mesna is a drug that breaks down adhesions between tissue layers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mesna | B. Mesna will be used to aid in the removal of the capsule when capsulectomy is performed |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2008-08-01
- Completion
- 2009-12-01
- First posted
- 2008-09-25
- Last updated
- 2014-12-10
- Results posted
- 2014-12-10
Source: ClinicalTrials.gov record NCT00758667. Inclusion in this directory is not an endorsement.